7Burroughs AK.Somatostatin and octreotide for variceal bleeding.J Hepatol,1991,13:1.
8Sieber C,Mosca PG,Grcazmann R.J. Effect of somatostain on mesenteric vasular resistance in normal and portal hypertension rats. Am J Physiol,1992,262:274.
3[1]Mc Cormick P A,Dick R,Siringo S,et al.Octreitide reduces azygous blood flow in cirrhotic patients with portal hypertension [J].Eur J Gastroenterol Heptol,1990,2:488
4[2]Shields R,Jenkins SA,Baxter JN,et al.A prospective reandomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesphageal varices [J].Hepatology,1992,16:128
5[4]Assisn EC,P orisio TM,Woltdring EA,et al.Suppresion of gastrin and gastric acid secretion in the Zollinge-Ellison syndrome by longaction somatostatin(SMS 201-995) [J].Scand J Gastroenterol (Suppl),1997,119:206
6[1]Reichen J.Liver function and pharmacological consideration in pathogenesis and treatment of portal hypertension.Hepatology,1990,11(6):1 066～1 078.
7[3]Jenkins SA,Baxter JN,Corbet WA,et al.Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in pig and on Intravariceal pressure in man.Br J Surg,1985,75(12):1 009-1 012.
8[4]Barrioz T,Borderie C,Strock P,et al.Effects of octreotide on lower esophageal sphincted in patients with cirrhosis and portol hypertension.Dig Dis Sci,1998,43(7):1 566-1 571.
9[5]Cello JP.Octreotide therapy for variceal hemorrhage.Digestion,1993,54(suppl):21.
10[6]Mckee RF.Sandostatin therapy of acute oesophageal variceal bleeding.Digestion,1993,54(suppl):27.
